Aidi injection combined with Chinese herbal compound for treatment of advanced primary liver cancer clinical concept.docVIP

 PAGE \* MERGEFORMAT 4 Aidi injection combined with Chinese herbal compound for treatment of advanced primary liver cancer clinical concept Authors: TIAN Yi-Chau Li Hong Huang Liping SHI Hui Ling-Yan Zhang Yan [Keywords:] Primary liver cancer Primary liver cancer is a common malignancy. From May 2006 to August 2007, the author of Aidi injection combined with Chinese herbal compound for treatment of advanced liver product side 30 cases of primary liver cancer have achieved good effect, are reported below. 1 Data and methods 1.1 General Information The Court in accordance with 30 patients ‘tumor volumes clinical practice guidelines’ [1] diagnostic criteria of primary liver cancer by clinical, pathological, radiological diagnosis of advanced primary liver cancer, after surgery, intervention or Local recurrence after ablation, residual lesions could not be further therapy, and extrahepatic metastasis occurred, no treatment or medical practitioners to be 3 months after treatment were to observe them. Using random number table is divided into treatment group (TCM symptomatic support therapy) 30 patients in control group (symptomatic supportive care alone) 30 cases. Male and 45 cases, female 15 cases; aged 45 to 76 years. Two groups in age, sex, disease has comparable. 1.2 Treatment Treatment group to be Aidi injection 60ml 5% glucose solution intravenously 500ml, 1 times / d, continued to 20d, after the repeat interval of 10d for a cycle, the application three cycles, and be the basis of liver product side to side, with the Certificate of Chinese medicine decoction plus or minus 1 / d taken orally for 3 months or more, while I support the appropriate symptomatic treatment. Control group, only to be symptomatic supportive care, liver protection JiangMei, diuretic, Huwei, pain and so on. 1.3 Observation Project Mainly observed before and after treatment in patients with measurable lesions and objective efficacy and quality of life changes, including the commo